APA

Riedinger J. M., Wafflart J., Ricolleau G., Eche N., Larbre H., Basuyau J. P., Dalifard I., Hacene K. & Pichon M. F. (20070104). CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Riedinger J M, Wafflart J, Ricolleau G, Eche N, Larbre H, Basuyau J P, Dalifard I, Hacene K and Pichon M F. 20070104. CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Riedinger J. M., Wafflart J., Ricolleau G., Eche N., Larbre H., Basuyau J. P., Dalifard I., Hacene K. and Pichon M. F. (20070104). CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Riedinger J M, Wafflart J, Ricolleau G, Eche N, Larbre H, Basuyau J P, Dalifard I, Hacene K and Pichon M F. CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study. : Annals of oncology : official journal of the European Society for Medical Oncology. 20070104.